| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1513/ANNALSATS.201506-348KV |
| P698 | PubMed publication ID | 27564668 |
| P2093 | author name string | David A Lomas | |
| P2860 | cites work | Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease | Q22299313 |
| Small molecules block the polymerization of Z alpha1-antitrypsin and increase the clearance of intracellular aggregates | Q24645055 | ||
| Risk loci for chronic obstructive pulmonary disease: a genome-wide association study and meta-analysis | Q29416987 | ||
| Standardization of Spirometry, 1994 Update. American Thoracic Society | Q29547574 | ||
| A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. | Q33419815 | ||
| Variants in FAM13A are associated with chronic obstructive pulmonary disease | Q33687879 | ||
| Characterisation of COPD heterogeneity in the ECLIPSE cohort | Q34149510 | ||
| The mechanism of Z alpha 1-antitrypsin accumulation in the liver | Q34440939 | ||
| Serum PARC/CCL-18 concentrations and health outcomes in chronic obstructive pulmonary disease | Q35042489 | ||
| Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis | Q35536791 | ||
| COPD association and repeatability of blood biomarkers in the ECLIPSE cohort | Q35637295 | ||
| Polymers of Z alpha1-antitrypsin co-localize with neutrophils in emphysematous alveoli and are chemotactic in vivo | Q35755014 | ||
| Association of IREB2 and CHRNA3 polymorphisms with airflow obstruction in severe alpha-1 antitrypsin deficiency | Q35837259 | ||
| COPD, a multicomponent disease: implications for management | Q36119043 | ||
| C-reactive protein in patients with COPD, control smokers and non-smokers | Q36148673 | ||
| Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease | Q37012728 | ||
| Outcomes for COPD pharmacological trials: from lung function to biomarkers. | Q37073253 | ||
| New Findings in PiZZ alpha1-antitrypsin deficiency-related panniculitis. Demonstration of skin polymers and high dosing requirements of intravenous augmentation therapy | Q37466723 | ||
| Club cell protein 16 and disease progression in chronic obstructive pulmonary disease | Q37566520 | ||
| Lessons from ECLIPSE: a review of COPD biomarkers | Q38169066 | ||
| C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease | Q40277494 | ||
| Quantitative isolation of alphalAT mutant Z protein polymers from human and mouse livers and the effect of heat | Q40518358 | ||
| Lung polymers in Z alpha1-antitrypsin deficiency-related emphysema | Q42454527 | ||
| Polymers of alpha(1)-antitrypsin are chemotactic for human neutrophils: a new paradigm for the pathogenesis of emphysema | Q42521815 | ||
| Systemic soluble receptor for advanced glycation endproducts is a biomarker of emphysema and associated with AGER genetic variants in patients with chronic obstructive pulmonary disease | Q43779676 | ||
| The presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: a prospective analysis from the ECLIPSE study | Q43875548 | ||
| Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD. | Q46150950 | ||
| Increased systemic inflammation is a risk factor for COPD exacerbations | Q46806112 | ||
| Z alpha1-antitrypsin polymerizes in the lung and acts as a neutrophil chemoattractant | Q47622881 | ||
| Exacerbations in subjects with alpha-1 antitrypsin deficiency receiving augmentation therapy. | Q47740528 | ||
| Exacerbations in {alpha}1-antitrypsin deficiency | Q47787819 | ||
| Should we view chronic obstructive pulmonary disease differently after ECLIPSE? A clinical perspective from the study team. | Q51159286 | ||
| Changes in forced expiratory volume in 1 second over time in COPD. | Q51521679 | ||
| Oxidation of Z α1-antitrypsin by cigarette smoke induces polymerization: a novel mechanism of early-onset emphysema. | Q51536039 | ||
| Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary disease. | Q53409072 | ||
| Systemic Inflammation and COPD | Q57072926 | ||
| Inflammatory Biomarkers Improve Clinical Prediction of Mortality in Chronic Obstructive Pulmonary Disease | Q57955696 | ||
| Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease | Q57955820 | ||
| Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE) | Q57955885 | ||
| Evaluation of serum CC-16 as a biomarker for COPD in the ECLIPSE cohort | Q58316998 | ||
| Circulating polymers in 1-antitrypsin deficiency | Q58966863 | ||
| ANCA-associated vasculitis is linked to carriage of the Z allele of 1 antitrypsin and its polymers | Q58967026 | ||
| P304 | page(s) | S326-31 | |
| P577 | publication date | 2016-08-01 | |
| P1433 | published in | Proceedings of the American Thoracic Society | Q7247176 |
| P1476 | title | An ECLIPSE View of Alpha-1 Antitrypsin Deficiency | |
| P478 | volume | 13 Suppl 4 |
| Q55666746 | Alpha-1 antitrypsin deficiency: outstanding questions and future directions. |
| Q55689873 | Cigarette smoke extract enhances neutrophil elastase-induced IL-8 production via proteinase-activated receptor-2 upregulation in human bronchial epithelial cells. |
| Q39173207 | Double-hit mouse model of cigarette smoke priming for acute lung injury |
| Q29091067 | Network biology concepts in complex disease comorbidities |
Search more.